Immune to Cancer: The CRI Blog
-
Introducing CRI’s IO Insights: Your Monthly Guide to the Latest in Immunotherapy
For over 70 years, the Cancer Research Institute (CRI) has been a leader in the fight against… -
Breaking Barriers: How Immunotherapy Targets Pancreatic Cancer
Cancer immunotherapy has helped transform treatment for patients with 29 forms of cancer. Some cancer types, like… -
5 Things You Need to Know About Liver Cancer
Liver cancer is one of the deadliest forms of the disease and is on the rise both… -
How 2 CRI Scientists Fight Cancer by Mimicking Infection and Characterizing Molecular Mechanisms in Immune Cells
Immunotherapy harnesses the power of the immune system to target cancer with precision. Approved by the FDA… -
How Targeting a Rare Blood Cancer Complication and Bacteria in Colorectal Cancer Can Bolster Immunotherapy Outcomes
Immunotherapy triggers the body’s immune system to effectively and precisely respond to cancer. However, immunotherapy is not… -
CICON24 Recap: Key Breakthroughs and Bold Conversations Shaping the Future of Immunotherapy
The Cancer Immunotherapy Conference (CICON24) opened with a palpable sense of urgency and optimism, bringing together the… -
Ovarian Cancer Awareness Month: How Immunotherapy Fights This High-Occurrence Malignancy
Ovarian cancer is one of several gynecologic malignancies, impacting about 300,000 women globally each year. September has… -
Key Discoveries from the AMADEUS Clinical Trial on Cancer Treatment
The Cancer Research Institute (CRI) is excited to share the findings from the AMADEUS clinical trial, which… -
How Immunotherapy Before Surgery Can Impact Patient Outcomes
For some cancer patients, immunotherapy can serve as a first-line treatment, while for others it can act…